Lilly will not fund programs where the principal focus is not educational in nature. Programs that are primarily entertainment, such as retirement dinners, medical school class reunions or staff recognition are outside the guidelines of the LGO. Non-medical educational programs (i.e. leadership training, business meetings) are also considered as out of scope. Finally, capital expenses and operating expenses are considered out of scope for the LGO.
The LGO will not fund budget line items such as, but not limited to, the following:
- Meals for audiences with under 50 participants
- Plated meals at any event for any audience size
- Gifts for faculty or organizers
- First class airfare
- Program/registration fees, travel or expenses for participants
- Salaries and benefits
- Capital, infrastructure or operating expenses such as office equipment, furniture, or facilities modifications.
Generally, when supporting an educational activity, the LGO will consider funding the following types of expenses:
- Honorarium for medical or scientific faculty, preferably for CME/CE only
- Speaker travel (coach), reasonable expenses for lodging and meals, preferably for CME/CE only
- Room rental related to the educational portion of the program
- A/V equipment rental
- Modest meal or refreshments for participants (buffet style for 50 or more participants only)
- Cost for CME/CE accreditation
- Meeting-related expenses (must be detailed in budget)
The LGO will consider proposals for all medical educational activities for health care providers; however, accredited programs for health care providers will receive the highest priority.
The grant review committees consider many factors in determining which programs to support including, but not limited to, the scientific quality of the program, the educational need, budget and audience reach.
There are limited funds available for such activities. While fundraising activities will be considered, there will be only a very limited number approved.
The Lilly Grant Office and all partner offices are independent of the sales and marketing organizations. Sales and marketing personnel have no role in the grant approval process. All Lilly personnel must respond to inquiries regarding a grant request by providing the requestor with the LGO telephone number or the LGO website address. The requestor is entirely responsible for submitting a grant request to the LGO, and all Lilly personnel are prohibited from contacting the LGO on behalf of any requestor. Lilly personnel cannot solicit grant funding requests and should provide the referral information if grants are brought up in an unsolicited manner by a customer.
Consistent with company policies, applicable FDA regulations, and rules of the ACCME and other accreditation groups, Lilly as a commercial supporter is not permitted to control the content of Continuing Medical Educational activities funded through grants. The LGO applies this policy to all educational activities funded through the Grant Office. Thus, it is possible that the educational programs funded by the company through grants have discussed off-label uses of our products. However, such content would have been independently determined by the grant recipient with no Lilly input.
The LGO receives, evaluates, and approves the vast majority of the grant requests the company receives. However, the Lilly Foundation and country-specific Lilly offices also provide grant funding.
Information about the scope of The Lilly Foundation can be found at http://www.lilly.com/about/lilly-foundation/Pages/lilly-foundation.aspx
Grant requests for country-specific educational programs and events taking place outside the United States are submitted to the Lilly office in that country, or the Lilly office responsible for operations in that country, for evaluation and funding consideration.
Lilly has guidelines and criteria in place to ensure we do not fund activities that would create a conflict of interest for Lilly or the funded organization.
Lilly provides grant funding to various organizations as a part of our mission to enhance patient care and improve the healthcare system. By adding transparency to our educational grant funding and charitable contributions, we are making available to the public the nature of the relationships between our company and these organizations.
Lilly will disclose to the public all educational grants and charitable contributions made by the Lilly Grant Office (LGO) to U.S.-based organizations. The company will update the website quarterly to include all new grant funding provided during that period. Via the website, the company will post the names of every organization receiving funding from Lilly in each quarter, including the grant amount and program title. Additionally, grants provided in cooperation with our alliance partner Daiichi Sankyo Co., Ltd are included in our prior years' reports.
We also disclose grant information per guidelines or requirements of the U.S. Physician Payment Sunshine Act ("Open Payments") – subpart of the Patient Protection and Affordable Care Act passed in 2010 and certain state laws.
Yes, we disclose grant information per guidelines or requirements of the following:
- European Federation of Pharmaceutical Industries and Associations (EFPIA) code on disclosure of transfers of value from Pharmaceutical Companies to Healthcare Organisations
- Other country codes on similar disclosures for patient organizations and healthcare organizations, as applicable